Market Place
Sourcing Support
Novo Nordisk Discloses Board and Executive Share Trades
07 Aug 2025 //
GLOBENEWSWIRE
Novo Nordisk Drops 2 Obesity Drugs as Part of Major Clearout
07 Aug 2025 //
FIERCE BIOTECH
Novo`s new CEO Takes Over at Difficult Time for Drugmaker
07 Aug 2025 //
FIERCE PHARMA
Wegovy maker Novo Nordisk to Reduce Costs After $95 billion stock
06 Aug 2025 //
REUTERS
Maziar Mike Doustdar Named Novo Nordisk`s President and CEO
31 Jul 2025 //
INDPHARMAPOST
FDA Approves Alhemo for Hemophilia A/B Treatment in Children
31 Jul 2025 //
PR NEWSWIRE
Obesity Drug Trials Underway in Big and Small Pharma Labs
31 Jul 2025 //
ECONOMICTIMES
FuturHealth to Distribute Affordable FDA-Approved GLP-1s
30 Jul 2025 //
PR NEWSWIRE
Novo Nordisk Names New President & CEO
29 Jul 2025 //
CONTRACTPHARMA
Novo Nordisk Reduces 2025 Sales and Profit Forecast
29 Jul 2025 //
GLOBENEWSWIRE
Maziar Mike Doustdar Named Novo Nordisk`s President and CEO
29 Jul 2025 //
GLOBENEWSWIRE
EU Adopts Positive Opinion for Novo Nordisk’s Alhemo
25 Jul 2025 //
GLOBENEWSWIRE
Dr Reddy`s Plan to Launch Generic of Novo`s Weight-Loss Drug
24 Jul 2025 //
REUTERS
Fangzhou, Novo Nordisk Sign Memo for Health Management Ecosystem
20 Jul 2025 //
GLOBENEWSWIRE
ET Graphics: Tirzepatide, Semaglutide lead India, misuse concerns
16 Jul 2025 //
ECONOMICTIMES
Novo Nordisk’s Biologic Norditropin Receives Suppl Approval in US
09 Jul 2025 //
FDA
Novo’s Biologic Norditropin Flexpro Receives Suppl Approval in US
09 Jul 2025 //
FDA
Novo’s Biologics Norditropin Receives Suppl Approval in US
09 Jul 2025 //
FDA
Novo Nordisk`s Biologics Sogroya Receive Suppl Approval in US
09 Jul 2025 //
FDA
Novo Adds $112 M Quality Testing Lab to List of China Investments
09 Jul 2025 //
FIERCE PHARMA
Novo Nordisk seeks EMA Approval For higher Wegovy Dose in Obesity
09 Jul 2025 //
INDPHARMAPOST
Eli Lilly Launches Mounjaro KwikPen for Type 2 Diabetes in India
08 Jul 2025 //
ECONOMICTIMES
Mounjaro Hits Rs 50 Cr Milestone in India as Wegovy Enters Market
08 Jul 2025 //
ECONOMICTIMES
Anti-obesity drug war heats up as Wegovy and Mounjaro boost sales
07 Jul 2025 //
BUSINESS STD
Novo`s Wegovy Retakes Top TV Spending Spot in June
07 Jul 2025 //
FIERCE PHARMA
Obesity Drugs Shoots up In India as Lilly, Novo for Market Share
07 Jul 2025 //
REUTERS
Delhi Hc Seeks Regulator`s Reply on Ozempic, Mounjaro Nod in Pil
03 Jul 2025 //
ECONOMICTIMES
Pros and Cons of Weight Loss Drugs
02 Jul 2025 //
EXPRESSPHARMA
Novo Misread the US Market for Its Weight Loss Sensation
02 Jul 2025 //
REUTERS
WeightWatchers, Novo Nordisk Expand Collaboration for Medication
01 Jul 2025 //
GLOBENEWSWIRE
India`s Biocon Drops Plan to Launch Weight-Loss Drugs in China
27 Jun 2025 //
REUTERS
Novo Nordisk Supports Patient Access to Wegovy and Safety
26 Jun 2025 //
PR NEWSWIRE
Novo Nordisk Launch $109M Protein Design Research Hub
25 Jun 2025 //
PR NEWSWIRE
Novo Nordisk Questioned Over Spanish Obesity Awareness Campaign
25 Jun 2025 //
FIERCE PHARMA
Weight-loss drug Wegovy starts at 17,345 in India
25 Jun 2025 //
ECONOMICTIMES
Novo Nordisk launches weight-loss drug Wegovy in India
25 Jun 2025 //
REUTERS
Novo Nordisk Aims for Heavy Sales in India with Wegovy
24 Jun 2025 //
#N/A
Novo Nordisk Ends Collaboration with Hims & Hers Health
24 Jun 2025 //
PR NEWSWIRE
EMA to Allow Novo to Include Heart Condition in Ozempic Label
24 Jun 2025 //
REUTERS
Novo Nordisk: Ozempic® recommended in EU for Peripheral Arterial
23 Jun 2025 //
GLOBENEWSWIRE
Novo Shares Fall as Obesity Pipeline Faces Investor Scrutiny
23 Jun 2025 //
REUTERS
Novo Nordisk: Mim8 Prophylaxis Well-Tolerated in Haemophilia A
22 Jun 2025 //
GLOBENEWSWIRE
Novo Nordisk`s experimental drug results in up to 24% weight loss
21 Jun 2025 //
PRESS RELEASE
Judge backs FDA`s Removal of Ozempic, Wegovy from Shortage list
18 Jun 2025 //
REUTERS
NVIDIA partners with Novo Nordisk and DCAI for drug discovery
13 Jun 2025 //
INDPHARMAPOST
Novo Nordisk plans to Start Late-stage Trials of Obesity Drug
13 Jun 2025 //
GLOBENEWSWIRE
EFPIA Urges EU to Streamline Clinical Trials Under Biotech Act
12 Jun 2025 //
RAPS
Novo Signs $812M Weight-Loss Drug License Deal with Deep Apple
12 Jun 2025 //
REUTERS
Novo Nordisk starts new CagriSema weightloss drug trial
11 Jun 2025 //
REUTERS
ADA 2025: Novo Nordisk showcases new semaglutide data, redefining
10 Jun 2025 //
GLOBENEWSWIRE
Parvus Hedge Fund Increases Novo Nordisk Stake, Ft Reports
09 Jun 2025 //
REUTERS
Novo`s Ozempic Linked to Rare Cases of Serious Eye Disorder
09 Jun 2025 //
REUTERS
Novo Nordisk to present phase 3 hemophilia trials at ISTH 2025
06 Jun 2025 //
PR NEWSWIRE
Exclusive: Wegovy use up 50% among US teens
03 Jun 2025 //
REUTERS
Legal battle Erupts before Novo Nordisk`s Wegovy launch
31 May 2025 //
ECONOMICTIMES
Wegovy Maker Novo Faces Fee Demand After Losing Copycat Drug Laws
29 May 2025 //
REUTERS
Weight-Loss Drug Discounts Fall Short, Copies Face US Crackdown
23 May 2025 //
REUTERS
GLP-1 diabetes drugs like Ozempic may modestly reduce cancer risks
23 May 2025 //
REUTERS
Novo Launches Access Programs As FDA Ban Hits Wegovy Copies
22 May 2025 //
PR NEWSWIRE
Time`s up For Compounders: Novo Offers One-Time Wegovy Deal
22 May 2025 //
FIERCE PHARMA
